{"id":37165,"date":"2025-03-25T10:43:28","date_gmt":"2025-03-25T09:43:28","guid":{"rendered":"https:\/\/www.organisator.ch\/?p=37165"},"modified":"2025-03-25T09:34:15","modified_gmt":"2025-03-25T08:34:15","slug":"remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien","status":"publish","type":"post","link":"https:\/\/www.organisator.ch\/en\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/","title":{"rendered":"Remuun receives CHF 150,000 from Venture Kick to promote targeted antibody therapies"},"content":{"rendered":"<figure id=\"attachment_37167\" aria-describedby=\"caption-attachment-37167\" style=\"width: 680px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-37167\" src=\"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg\" alt=\"\" width=\"680\" height=\"453\" srcset=\"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg 680w, https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps-18x12.jpg 18w, https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps-375x250.jpg 375w, https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps-525x350.jpg 525w\" sizes=\"auto, (max-width: 680px) 100vw, 680px\" \/><figcaption id=\"caption-attachment-37167\" class=\"wp-caption-text\">Remuun receives CHF 150,000 from Venture Kick for a platform to accelerate the development of precise antibodies against cancer. (Image: Venture Kick)<\/figcaption><\/figure>\n<p>The global market for monoclonal antibodies is expected to grow to over USD 300 billion by 2025. However, current antibody development processes are often slow, costly and limited in their therapeutic range, making it difficult to develop new therapies, particularly for cancer and diseases of the immune system.<\/p>\n<p>Remuun has developed a patented MEGA platform that mimics the natural process of antibody diversification in the laboratory. Its modular design enables the rapid and precise production of customized monoclonal antibodies. Based on its expertise in the interactions between the immune system and tumors, Remuun aims to deepen scientific understanding and develop more effective immunotherapies.<\/p>\n<p>The biotech startup plans to use the CHF 150,000 provided by Venture Kick to accelerate its growth. The funds will be used to build strategic partnerships with pharmaceutical companies, drive the development of a new generation of antibody-based therapies and expand the intellectual property portfolio.<\/p>\n<p>The REMUUN team, co-founded by Prof. Dr. Richard Chahwan, consists of the scientists Paulina Wyrzykowska and Romina Fetti as well as other advisors. They bring diverse and complementary expertise to the development of innovative antibody therapies<\/p>\n<p>\"Venture Kick has provided Remuun with crucial support: The funding, mentoring and access to a broad network of experts have not only accelerated our research, but also sharpened our business strategy,\" says Richard Chahwan, founder and CEO of Remuun. \"The process has challenged us to think bigger, evolve our vision and position Remuun as an innovator in antibody development. We greatly appreciate this support and look forward to the next steps.\"<\/p>\n<p><em><a href=\"https:\/\/www.venturekick.ch\/remuun\">More information<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Remuun, a spin-off of the University of Zurich, receives CHF 150,000 from Venture Kick for the development of a modular platform that accelerates the discovery of precision antibodies. The aim is to improve immunotherapies for the treatment of cancer and related diseases.<\/p>","protected":false},"author":80,"featured_media":37167,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_yoast_wpseo_focuskw":"Remuun","_yoast_wpseo_metadesc":"Remuun erh\u00e4lt CHF 150'000 von Venture Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser Antik\u00f6rper gegen Krebs.","articlekey":"","footnotes":""},"categories":[28],"tags":[5233,1441,2195,2425,3934],"class_list":["post-37165","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-management","tag-immuntherapie","tag-investition","tag-start-up","tag-uzh","tag-venture-kick"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Remuun erh\u00e4lt CHF 150&#039;000 von Venture Kick zur F\u00f6rderung zielgerechter Antik\u00f6rpertherapien - Organisator<\/title>\n<meta name=\"description\" content=\"Remuun erh\u00e4lt CHF 150&#039;000 von Venture Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser Antik\u00f6rper gegen Krebs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.organisator.ch\/en\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Remuun erh\u00e4lt CHF 150&#039;000 von Venture Kick\" \/>\n<meta property=\"og:description\" content=\"Remuun erh\u00e4lt CHF 150&#039;000 von Venture Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser Antik\u00f6rper gegen Krebs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.organisator.ch\/en\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/\" \/>\n<meta property=\"og:site_name\" content=\"Organisator\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OrganisatorFachmagazin\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-25T09:43:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"680\" \/>\n\t<meta property=\"og:image:height\" content=\"453\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dzana Muminovic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Remuun erh\u00e4lt CHF 150&#039;000 von Venture Kick\" \/>\n<meta name=\"twitter:description\" content=\"#Remuun erh\u00e4lt CHF 150&#039;000 von #Venture #Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser #Antik\u00f6rper gegen #Krebs.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/\"},\"author\":{\"name\":\"Dzana Muminovic\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/person\\\/afccda3a71c06d4be2ed9100dd163db7\"},\"headline\":\"Remuun erh\u00e4lt CHF 150&#8217;000 von Venture Kick zur F\u00f6rderung zielgerechter Antik\u00f6rpertherapien\",\"datePublished\":\"2025-03-25T09:43:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/\"},\"wordCount\":303,\"publisher\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Venture-Kick_Bild1_ps.jpg\",\"keywords\":[\"Immuntherapie\",\"Investition\",\"Start-up\",\"UZH\",\"Venture Kick\"],\"articleSection\":[\"MANAGEMENT\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/\",\"name\":\"Remuun erh\u00e4lt CHF 150'000 von Venture Kick zur F\u00f6rderung zielgerechter Antik\u00f6rpertherapien - Organisator\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Venture-Kick_Bild1_ps.jpg\",\"datePublished\":\"2025-03-25T09:43:28+00:00\",\"description\":\"Remuun erh\u00e4lt CHF 150'000 von Venture Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser Antik\u00f6rper gegen Krebs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Venture-Kick_Bild1_ps.jpg\",\"contentUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Venture-Kick_Bild1_ps.jpg\",\"width\":680,\"height\":453,\"caption\":\"Remuun erh\u00e4lt CHF 150'000 von Venture Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser Antik\u00f6rper gegen Krebs. (Bild: Venture Kick)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/management\\\/2025-03-25\\\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.organisator.ch\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Remuun erh\u00e4lt CHF 150&#8217;000 von Venture Kick zur F\u00f6rderung zielgerechter Antik\u00f6rpertherapien\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/\",\"name\":\"Organisator\",\"description\":\"Kompetent. Praxisnah. Der ORGANISATOR bereitet in 10 Ausgaben pro Jahr die wesentlichen Themen f\u00fcr F\u00fchrungskr\u00e4fte von KMU auf.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.organisator.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#organization\",\"name\":\"Organisator\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Logo_Organisator_Website.png\",\"contentUrl\":\"https:\\\/\\\/www.organisator.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Logo_Organisator_Website.png\",\"width\":800,\"height\":77,\"caption\":\"Organisator\"},\"image\":{\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/OrganisatorFachmagazin\",\"https:\\\/\\\/www.linkedin.com\\\/showcase\\\/organisator-das-magazin-fr-kmu\",\"https:\\\/\\\/www.xing.com\\\/news\\\/pages\\\/organisator-ch-695\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCGP2Sq0iWaZwT3BdIAQFYpw\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.organisator.ch\\\/#\\\/schema\\\/person\\\/afccda3a71c06d4be2ed9100dd163db7\",\"name\":\"Dzana Muminovic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/909c5c71aff4b38e88686f2ab2f1ba152571f394f41ed8bae431ea56ced93050?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/909c5c71aff4b38e88686f2ab2f1ba152571f394f41ed8bae431ea56ced93050?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/909c5c71aff4b38e88686f2ab2f1ba152571f394f41ed8bae431ea56ced93050?s=96&d=mm&r=g\",\"caption\":\"Dzana Muminovic\"},\"url\":\"https:\\\/\\\/www.organisator.ch\\\/en\\\/author\\\/dzana-muminovic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Remuun receives CHF 150,000 from Venture Kick to promote targeted antibody therapies - Organizer","description":"Remuun receives CHF 150,000 from Venture Kick for a platform to accelerate the development of precise antibodies against cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.organisator.ch\/en\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/","og_locale":"en_US","og_type":"article","og_title":"Remuun erh\u00e4lt CHF 150'000 von Venture Kick","og_description":"Remuun erh\u00e4lt CHF 150'000 von Venture Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser Antik\u00f6rper gegen Krebs.","og_url":"https:\/\/www.organisator.ch\/en\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/","og_site_name":"Organisator","article_publisher":"https:\/\/www.facebook.com\/OrganisatorFachmagazin","article_published_time":"2025-03-25T09:43:28+00:00","og_image":[{"width":680,"height":453,"url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg","type":"image\/jpeg"}],"author":"Dzana Muminovic","twitter_card":"summary_large_image","twitter_title":"Remuun erh\u00e4lt CHF 150'000 von Venture Kick","twitter_description":"#Remuun erh\u00e4lt CHF 150'000 von #Venture #Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser #Antik\u00f6rper gegen #Krebs.","twitter_image":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/#article","isPartOf":{"@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/"},"author":{"name":"Dzana Muminovic","@id":"https:\/\/www.organisator.ch\/#\/schema\/person\/afccda3a71c06d4be2ed9100dd163db7"},"headline":"Remuun erh\u00e4lt CHF 150&#8217;000 von Venture Kick zur F\u00f6rderung zielgerechter Antik\u00f6rpertherapien","datePublished":"2025-03-25T09:43:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/"},"wordCount":303,"publisher":{"@id":"https:\/\/www.organisator.ch\/#organization"},"image":{"@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/#primaryimage"},"thumbnailUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg","keywords":["Immuntherapie","Investition","Start-up","UZH","Venture Kick"],"articleSection":["MANAGEMENT"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/","url":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/","name":"Remuun receives CHF 150,000 from Venture Kick to promote targeted antibody therapies - Organizer","isPartOf":{"@id":"https:\/\/www.organisator.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/#primaryimage"},"image":{"@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/#primaryimage"},"thumbnailUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg","datePublished":"2025-03-25T09:43:28+00:00","description":"Remuun receives CHF 150,000 from Venture Kick for a platform to accelerate the development of precise antibodies against cancer.","breadcrumb":{"@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/#primaryimage","url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg","contentUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2025\/03\/Venture-Kick_Bild1_ps.jpg","width":680,"height":453,"caption":"Remuun erh\u00e4lt CHF 150'000 von Venture Kick f\u00fcr eine Plattform zur schnelleren Entwicklung pr\u00e4ziser Antik\u00f6rper gegen Krebs. (Bild: Venture Kick)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.organisator.ch\/management\/2025-03-25\/remuun-erhaelt-chf-150000-von-venture-kick-zur-foerderung-zielgerechter-antikoerpertherapien\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.organisator.ch\/"},{"@type":"ListItem","position":2,"name":"Remuun erh\u00e4lt CHF 150&#8217;000 von Venture Kick zur F\u00f6rderung zielgerechter Antik\u00f6rpertherapien"}]},{"@type":"WebSite","@id":"https:\/\/www.organisator.ch\/#website","url":"https:\/\/www.organisator.ch\/","name":"Organizer","description":"Competent. Practical. In 10 issues per year, ORGANISATOR presents the essential topics for managers of SMEs.","publisher":{"@id":"https:\/\/www.organisator.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.organisator.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.organisator.ch\/#organization","name":"Organizer","url":"https:\/\/www.organisator.ch\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.organisator.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2022\/01\/Logo_Organisator_Website.png","contentUrl":"https:\/\/www.organisator.ch\/wp-content\/uploads\/2022\/01\/Logo_Organisator_Website.png","width":800,"height":77,"caption":"Organisator"},"image":{"@id":"https:\/\/www.organisator.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OrganisatorFachmagazin","https:\/\/www.linkedin.com\/showcase\/organisator-das-magazin-fr-kmu","https:\/\/www.xing.com\/news\/pages\/organisator-ch-695","https:\/\/www.youtube.com\/channel\/UCGP2Sq0iWaZwT3BdIAQFYpw"]},{"@type":"Person","@id":"https:\/\/www.organisator.ch\/#\/schema\/person\/afccda3a71c06d4be2ed9100dd163db7","name":"Dzana Muminovic","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/909c5c71aff4b38e88686f2ab2f1ba152571f394f41ed8bae431ea56ced93050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/909c5c71aff4b38e88686f2ab2f1ba152571f394f41ed8bae431ea56ced93050?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/909c5c71aff4b38e88686f2ab2f1ba152571f394f41ed8bae431ea56ced93050?s=96&d=mm&r=g","caption":"Dzana Muminovic"},"url":"https:\/\/www.organisator.ch\/en\/author\/dzana-muminovic\/"}]}},"_links":{"self":[{"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/posts\/37165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/users\/80"}],"replies":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/comments?post=37165"}],"version-history":[{"count":4,"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/posts\/37165\/revisions"}],"predecessor-version":[{"id":37200,"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/posts\/37165\/revisions\/37200"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/media\/37167"}],"wp:attachment":[{"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/media?parent=37165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/categories?post=37165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.organisator.ch\/en\/wp-json\/wp\/v2\/tags?post=37165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}